216 related articles for article (PubMed ID: 27558979)
21. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.
; Vallejo-Vaz AJ; Akram A; Kondapally Seshasai SR; Cole D; Watts GF; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Freiberger T; Abifadel M; Aguilar-Salinas CA; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Ceska R; Corral P; Descamps O; Dieplinger H; Do CT; Durst R; Ezhov MV; Fras Z; Gaita D; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Lin J; Lin N; Maher V; Majano N; Marais AD; März W; Mirrakhimov E; Miserez AR; Mitchenko O; Nawawi H; Nilsson L; Nordestgaard BG; Paragh G; Petrulioniene Z; Pojskic B; Reiner Ž; Sahebkar A; Santos LE; Schunkert H; Shehab A; Slimane MN; Stoll M; Su TC; Susekov A; Tilney M; Tomlinson B; Tselepis AD; Vohnout B; Widén E; Yamashita S; Catapano AL; Ray KK
Atheroscler Suppl; 2016 Dec; 22():1-32. PubMed ID: 27939304
[TBL] [Abstract][Full Text] [Related]
22. Cellular senescence, telomeres, and cardiovascular risk in familial hypercholesterolaemia.
Banach M; Penson PE
Eur J Prev Cardiol; 2022 May; 29(5):718-720. PubMed ID: 33624078
[No Abstract] [Full Text] [Related]
23. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
[TBL] [Abstract][Full Text] [Related]
24. Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia.
Koeijvoets KC; Mooijaart SP; Dallinga-Thie GM; Defesche JC; Steyerberg EW; Westendorp RG; Kastelein JJ; van Hagen PM; Sijbrands EJ
Eur Heart J; 2009 Mar; 30(5):618-23. PubMed ID: 19098018
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular Disease Risk Associated With Familial Hypercholesterolemia: A Systematic Review of the Literature.
Wong B; Kruse G; Kutikova L; Ray KK; Mata P; Bruckert E
Clin Ther; 2016 Jul; 38(7):1696-709. PubMed ID: 27261205
[TBL] [Abstract][Full Text] [Related]
26. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.
Atherosclerosis; 1999 Jan; 142(1):105-12. PubMed ID: 9920511
[TBL] [Abstract][Full Text] [Related]
27. Behavioural cardiovascular risk factors and prevalence of diabetes in subjects with familial hypercholesterolaemia.
Perez-Calahorra S; Civeira F; Guallar-Castillón P; Pinto X; Banegas JR; Pedro-Botet J; Suarez-Tembra M; Mauri M; Soler C; Rodriguez-Artalejo F; Laclaustra M
Eur J Prev Cardiol; 2020 Oct; 27(15):1649-1660. PubMed ID: 31914797
[TBL] [Abstract][Full Text] [Related]
28. A comparison of European and US guidelines for familial hypercholesterolaemia.
Reiner Ž
Curr Opin Lipidol; 2015 Jun; 26(3):215-20. PubMed ID: 25943839
[TBL] [Abstract][Full Text] [Related]
29. Familial hypercholesterolemia mutations in the Middle Eastern and North African region: a need for a national registry.
Bamimore MA; Zaid A; Banerjee Y; Al-Sarraf A; Abifadel M; Seidah NG; Al-Waili K; Al-Rasadi K; Awan Z
J Clin Lipidol; 2015; 9(2):187-94. PubMed ID: 25911074
[TBL] [Abstract][Full Text] [Related]
30. [Application of gene technology in the diagnosis of familial hypercholesterolemia].
Leren TP; Bakken KS; Rødningen OK; Gundersen KE; Sundvold H; Berg K; Tonstad S; Ose L
Tidsskr Nor Laegeforen; 1997 Feb; 117(5):678-81. PubMed ID: 9102960
[TBL] [Abstract][Full Text] [Related]
31. Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia.
Jansen AC; van Aalst-Cohen ES; Tanck MW; Cheng S; Fontecha MR; Li J; Defesche JC; Kastelein JJ
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1475-81. PubMed ID: 15879303
[TBL] [Abstract][Full Text] [Related]
32. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome.
Sjouke B; Kusters DM; Kindt I; Besseling J; Defesche JC; Sijbrands EJ; Roeters van Lennep JE; Stalenhoef AF; Wiegman A; de Graaf J; Fouchier SW; Kastelein JJ; Hovingh GK
Eur Heart J; 2015 Mar; 36(9):560-5. PubMed ID: 24585268
[TBL] [Abstract][Full Text] [Related]
33. Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece.
Diakou M; Miltiadous G; Xenophontos SL; Manoli P; Cariolou MA; Elisaf M
Eur J Intern Med; 2011 Oct; 22(5):e55-9. PubMed ID: 21925044
[TBL] [Abstract][Full Text] [Related]
34. Peripheral arterial disease in heterozygous familial hypercholesterolemia.
Pereira C; Miname MH; Makdisse MR; Watanabe C; Pesaro AE; Jannes CE; Kalil Filho R; Pereira AC; Santos RD
Atherosclerosis; 2015 Sep; 242(1):174-8. PubMed ID: 26201001
[TBL] [Abstract][Full Text] [Related]
35. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers.
Besseling J; Kindt I; Hof M; Kastelein JJ; Hutten BA; Hovingh GK
Atherosclerosis; 2014 Mar; 233(1):219-23. PubMed ID: 24529147
[TBL] [Abstract][Full Text] [Related]
36. The relationship of vitamin D status to risk of cardiovascular disease and mortality.
Skaaby T
Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634511
[TBL] [Abstract][Full Text] [Related]
37. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
[TBL] [Abstract][Full Text] [Related]
38. A functional polymorphism in the glucocorticoid receptor gene and its relation to cardiovascular disease risk in familial hypercholesterolemia.
Koeijvoets KC; van Rossum EF; Dallinga-Thie GM; Steyerberg EW; Defesche JC; Kastelein JJ; Lamberts SW; Sijbrands EJ
J Clin Endocrinol Metab; 2006 Oct; 91(10):4131-6. PubMed ID: 16849409
[TBL] [Abstract][Full Text] [Related]
39. Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease.
Yudi M; Omera L; McCubbery N; Dick S; Jayasinghe R; Hamilton-Craig I
Singapore Med J; 2012 Mar; 53(3):174-8. PubMed ID: 22434290
[TBL] [Abstract][Full Text] [Related]
40. Prediction of cardiovascular risk in patients with familial hypercholesterolaemia.
Villa G; Wong B; Kutikova L; Ray KK; Mata P; Bruckert E
Eur Heart J Qual Care Clin Outcomes; 2017 Oct; 3(4):274-280. PubMed ID: 29044394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
